Image created by Dr. Michael J. Miller
AIG Hospitals announced the introduction of PYtest, a non-invasive diagnostic test for detecting active Helicobacter pylori infections. The test has been developed by Nobel Laureate Barry Marshall. The test will be available at both the Gachibowli and Banjara Hills branches of the hospital.
Helicobacter pylori is among the most common bacterial infections in India and is associated with chronic gastritis, peptic ulcer disease, gastric cancer and MALT lymphoma. Despite its high prevalence, diagnosis has largely depended on invasive endoscopy-based procedures, often resulting in delayed or missed detection.
Announcing the launch, Dr. D. Nageshwar Reddy, Chairman, AIG Hospitals, said the new test would significantly improve patient comfort and encourage early screening. “The test eliminates the fear and hesitation associated with invasive procedures and brings us one step closer to early detection and prevention of serious gastric diseases,” he said.
PYtest is a Urea [14C] Breath Test that provides both qualitative and quantitative results. It enables physicians not only to confirm the presence of infection but also to assess the degree of bacterial activity. Unlike conventional diagnostic methods such as endoscopy and biopsy-based Rapid Urease Tests, the PYtest does not require invasive procedures or anaesthesia and delivers results within minutes, making it safer and more convenient for patients.
To implement the testing facility, AIG Hospitals has constituted a dedicated clinical team of gastroenterologists comprising Dr. Aniruddha Pratap Singh, Dr. Krithi Krishna and Dr. Rakesh Garlapati, under the supervision of Dr. Rakesh Kalapala.